STALICLA-SA
11.4.2024 13:01:32 CEST | Business Wire | Press release
STALICLA SA, a Swiss clinical-stage biotechnology company focused on advancing precision medicine for brain diseases, announced today the appointment of Thomas Blaettler, to the position of Chief Medical Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240411118139/en/
Thomas Blaettler, MD, joins STALICLA as Chief Medical Officer. (Photo: Business Wire)
Dr. Thomas Blaettler brings a wealth of pharmaceutical development experience and deep insights to help progress STALICLA’s ambitions in CNS conditions. He is a board-certified neurologist with 30 years’ experience in neuroscience, both in clinical residency and within the industry (Novartis, BMS, Roche, Orphazyme, Coave Therapeutics, Vectura Fertin Pharma).
As a clinician, he is driven by the desire to advance clinical research for the benefit of patients who are in dire need of better treatments. He has published both preclinical and clinical research articles in top-tier journals such as Nature, Cell, PNAS and Lancet. With time, he has assumed roles with increasing strategic responsibility, overseeing global clinical development programs from Phase 1 to Phase 3.
Thomas has profound regulatory experience across the globe (EMA, FDA, PMDA, CFDA) from pre-IND interaction to submissions of NDAs and MAAs. As Chief Medical Officer at Orphazyme, he established a clinical development and regulatory organization, overseeing four late-stage development programs. In recent years, he was instrumentally involved in two successful IPOs at the Copenhagen and New York Nasdaq stock exchanges. Thomas completed his Doctor of Medicine at the University of Zurich and gained board certification from the Swiss Society of Neurology in 2003.
“We are delighted to welcome Thomas during a pivotal time where his proven track record in navigating clinical and strategic development will support the advancement of STALICLA’s late-stage Phase 2 and 3 clinical pipelines for precision medicine treatment of neurological and neuropsychiatric disorders. His focus on biomarker lead strategies in CNS drug development is an ideal fit with our science and vision to pioneer precision medicine in the neurodevelopmental disorder space.” - Lynn Durham, CEO & Founder.
“I am thrilled to be joining STALICLA, a biotechnical company that is leading the way in future precision medicine in NDDs and other CNS disorders. Moving away from the one size fits all concept in drug development, with modest if at all treatment effects, to tailored treatments that take into account the clinical and pathophysiological heterogeneity of patient populations will revolutionize the way we treat patients.”- Thomas Blaettler, MD.
About STALICLA
STALICLA SA is a Swiss clinical-stage biopharmaceutical company, pioneering precision treatment in neurodevelopmental and neuropsychiatric disorders. With an advanced clinical pipeline of phase 2 and 3 ready assets and an AI-driven precision neuro medicine platform for patient-drug matching, STALICLA is changing the landscape of brain disease treatment. For more information, please visit: https://stalicla.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240411118139/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ZincFive Announces Nickel-Zinc Retrofit Kit to Modernize Existing UPS Energy Storage Infrastructure8.4.2026 14:05:00 CEST | Press release
A turnkey, safe, scalable drop-in upgrade for existing UPS systems with a long-life, sustainable alternative to lead-acid ZincFive®, the global leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, today announced the NiZn Retrofit Kit, an uninterruptible power supply (UPS) energy storage solution designed to bring the benefits of modern battery chemistry to existing UPS battery systems in mission-critical environments. The NiZn Retrofit Kit will enable data center operators and service providers to replace legacy valve-regulated lead-acid (VRLA) batteries with ZincFive’s long-life, high-performance nickel-zinc technology without requiring cabinet enclosure replacement, system redesign, or operational disruption. As data center power demands continue to increase, operators face growing pressure to improve reliability, reduce lifecycle costs, and meet sustainability targets. At the same time, much of the global UPS energy storage system installed base re
New Research Finds AI Is Now Foundational to Modern Marketing8.4.2026 14:00:00 CEST | Press release
AI’s Impact on Marketing Doubles as Teams Move from Experimentation to Embedded Use NetApp® (NASDAQ: NTAP), the Intelligent Data Infrastructure company, today announced its participation in a new marketing research study conducted by Callan Consulting, a Silicon Valley executive marketing consulting firm, joining 18 B2B and B2C technology companies to examine how AI is reshaping modern marketing organizations, marking a clear shift from early experimentation to embedded, enterprise‑wide adoption. According to the State of AI in Technology Marketing 2026 report, based on in‑depth interviews with CMOs and senior marketing leaders at the participating companies, the study finds that AI is becoming rapidly integrated across core marketing teams and workflows—from content development and research to campaign optimization and analytics. As adoption deepens, data quality, accessibility, and governance are emerging as critical priorities. "AI doesn't change what great marketing is supposed to
Sagard and Unigestion Announce Closing of Partnership Transaction8.4.2026 14:00:00 CEST | Press release
Transaction completion marks the formal expansion of a strengthened global platform: Sagard Private Equity Solutions Sagard, a global multi-strategy alternative asset management firm with over $45 billion USD1 in assets under management and Unigestion Private Equity Holding SA (UNG PE), a leading middle market private equity provider, today announced the successful closing of their combination transaction, originally announced in September. Completion of this transaction marks the formal launch of the partnership and the integration of UNG PE into Sagard’s global middle-market private equity platform, Sagard Private Equity Solutions (SPES). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408374851/en/ “We are thrilled to formally begin our partnership with the Unigestion team,” said Paul Desmarais III, Chairman & CEO of Sagard. “This milestone solidifies our joint commitment to building a global private equity platform pos
Telia to Deploy Seamless OS Following Acquisition of Telness Operator8.4.2026 13:16:00 CEST | Press release
Today, Nordic Communications Group AB, parent company of Telness Tech, announced it will divest its mobile virtual network operator (MVNO) Telness to Telia in Sweden. As part of the transaction, Telness will sign a long-term agreement with Telness Tech for continued use of the Seamless OS technology platform, ensuring a smooth digital customer experience. At closing, Telia will become the first mobile network operator (MNO) to deploy Seamless OS. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260408876675/en/ Telness Tech executive leadership team on the announcement that Telia will be the first Mobile Network Operator (MNO) deploying Seamless OS. From the left, Sergio Budkin; CRO, Martina Klingvall; Founder and CEO, Sebastian Stecki; CMO, Pablo Noguerol; COO, Christina Berggren; VP Customer, Delivery & Product, Jonas Cedenwing; Founder and CTO. "For Seamless OS to be brought into an MNO environment such as Telia's is a defi
NIQ and Adsquare Collaborate to Bring GeoPurchase Audiences to the Programmatic Ecosystem Across Europe and North America8.4.2026 13:00:00 CEST | Press release
Relationship enables advertisers with local audience segments based on real‑world purchase behaviors. NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced a new collaboration with Adsquare, a global location intelligence platform, to make NIQ’s GeoPurchase audience segments available within the Adsquare platform for privacy‑safe activation across Europe and North America. The relationship provides advertisers with NIQ‑built GeoPurchase segments informed by industry‑leading CPG purchase insights, enabling more precise planning and targeting across cross‑screen and digital out‑of‑home (DOOH) campaigns. NIQ’s GeoPurchase audiences are derived from anonymized, local purchase insights that reflect real‑world shopping behaviors across a wide variety of categories and retailers—not lookalike or proxy audiences. Within Adsquare’s platform, these audience segments are enriched by location‑intelligent tools that help advertisers plan and activate programmatic campaigns with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom